Inside the research
Repligen Corporation
RGEN Research profile · latest available data
Price overview
$189.68
▼ -0.97 (-0.5%)
| 52w hi | $190.65 |
|---|---|
| 52w lo | $102.87 |
| Vol | 1.50M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.15
| Short | -0.18 |
|---|---|
| Medium | +0.06 |
| Long | -0.50 |
computed 2026-09-27
Key fundamentals
Repligen Corporation
Healthcare · Medical Instruments & Supplies
| Market cap | $10.70B |
|---|---|
| Enterprise value | $10.59B |
| Trailing P/E | 263.44x |
| Forward P/E | 71.58x |
| EV / EBITDA | 73.46x |
| P / S (ttm) | 13.63x |
| Profit margin | 5.3% |
| Return on equity | 2.0% |
| Revenue growth | +11.9% |
| Earnings growth | -65.9% |
| Debt / equity | 32.72 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.11 | |
| Sector | +0.08 | |
| Technical | +0.26 | |
| Earnings | +0.00 | |
| Sentiment | -0.68 |
macro × 1.00 · 2026-09-27
Business overview
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Risk Metrics
| Beta vs SPX | 1.41 |
|---|---|
| Corr SPX | 0.46 |
| Annual vol | 49.0% |
| Annual ret | +26.1% |
| Sharpe | 0.53 |
| Max DD | -41.0% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-28 | Earnings Release, Exhibits | read |
| 2026-07-22 | Material Agreement, Earnings Release… | read |
| 2026-05-15 | Shareholder Vote | read |
| 2026-05-05 | Earnings Release, Exhibits | read |
| 2026-02-24 | Earnings Release, Exhibits | read |
| 2026-01-06 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-10-28 | Earnings Release, Exhibits | read |
| 2025-09-02 | Officer / Director Change, Exhibits | read |
| 2025-07-29 | Earnings Release, Exhibits | read |
| 2025-05-15 | Bylaws Amendment, Shareholder Vote… | read |
| 2025-04-29 | Earnings Release, Exhibits | read |
| 2025-02-20 | Earnings Release, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 99.3% |
| HHI | 4,050 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Capital Research / Capital World | $108.47M | 795.01K |
| Citadel Advisors | $58.27M | 427.11K |
| State Street Corp | $15.32M | 14.95M |
| Fidelity / FMR LLC | $8.29M | 8.11M |
| Millennium Management | $3.68M | 27.00K |
| AQR Capital Management | $1.21M | 8.94K |
| T. Rowe Price Group | $239.08K | 1.75M |
As of 2026-06-30
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $32.45M | +7.2% | |
| Gross profit | $39.98M | +55.2% | |
| Operating income | $47.70M | +33.0% | |
| Net income | $35.60M | +29.7% | |
| Cash from ops | $113.92M | +51.5% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $189.92 | $191.51 | $186.91 | $189.68 | 1.50M |
| Sep 24 | $184.10 | $192.49 | $183.75 | $190.65 | 1.60M |
| Sep 23 | $186.38 | $188.95 | $181.71 | $184.53 | 934.80K |
| Sep 22 | $180.72 | $188.20 | $180.00 | $186.75 | 1.16M |
| Sep 21 | $176.89 | $182.25 | $176.22 | $180.71 | 857.60K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →